Educational Intervention for Patients Undergoing Cardiac Surgery
CARDIO-EDU
Effectiveness of a Nursing Intervention for the Preparation and Follow-up of Patients Undergoing Cardiovascular Surgery. Design and Evaluation of a Nursing Educational Program for the Preparation and Follow-up of Patients Undergoing Cardiovascular Surgery.
1 other identifier
interventional
261
1 country
1
Brief Summary
Cardiovascular surgery is associated with high levels of anxiety, uncertainty, and postoperative complications. Educational interventions led by nurses may improve patients' psychological adaptation, self-care abilities, and recovery outcomes. This randomized controlled trial aims to evaluate the effectiveness of a nurse-led educational program designed to prepare and support patients undergoing cardiovascular surgery. Participants are randomly assigned to either an intervention group receiving a structured perioperative educational program or a control group receiving usual care. The primary outcome is anxiety. Secondary outcomes include posoperative complications, patient satisfaction, pain intensity, length of ICU Stay, length of Hospital Stay, Body Mass Index, blood pressure, fasting blood glucose, Glycated Hemoglobin (HbA1c) and total Cholesterol. Participants are followed for six months after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2026
CompletedFirst Submitted
Initial submission to the registry
June 17, 2026
CompletedFirst Posted
Study publicly available on registry
July 2, 2026
CompletedJuly 8, 2026
June 1, 2026
2 years
June 17, 2026
July 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Anxiety
Anxiety assessed using the Hospital Anxiety and Depression Scale (HADS). Total HADS scores range from 0 to 42, with higher scores indicating greater emotional distress.
Baseline through 6 months after surgery
Secondary Outcomes (10)
Postoperative Complications
From surgery until 6 months post-surgery
Pain Intensity
Hospitalization through 6 months post-surgery
Patient Satisfaction
6 months post-surgery
Length of ICU Stay
From ICU admission after surgery until ICU discharge during the index hospitalization (up to 15 days after surgery).
Length of Hospital Stay
From hospital admission until hospital discharge (up to 30 days after surgery)
- +5 more secondary outcomes
Study Arms (2)
Experimental Group
EXPERIMENTALNurse-Led Educational Intervention
Control Group
NO INTERVENTIONUsual Care
Interventions
A structured nurse-led educational program delivered throughout the perioperative period for patients undergoing cardiovascular surgery. The intervention included preoperative education, preparation for surgery, postoperative recovery guidance, self-care education, symptom management, lifestyle recommendations, and follow-up support after hospital discharge. The program aimed to reduce anxiety and improve self-efficacy, self-care, and recovery outcomes.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older.
- Patients undergoing first-time cardiac surgery.
- Ability to understand and communicate in Spanish or Catalan.
- Provision of written informed consent.
You may not qualify if:
- Refusal or inability to provide informed consent.
- Previous cardiovascular surgery.
- Transcatheter aortic valve implantation (TAVI) or other percutaneous procedures.
- Cardiogenic shock before surgery requiring sedation and endotracheal intubation.
- Psychiatric disorders requiring treatment, including anxiety disorders, depression, alcoholism, dementia, psychosis, schizophrenia, amnesia, or personality disorders.
- Severe chronic diseases, including cirrhosis, hepatitis B or C, HIV/AIDS, Parkinson's disease, severe autoimmune disorders, blindness, or severe hearing impairment.
- Intensive care unit stay longer than 15 days after surgery.
- Death during hospitalization, including perioperative mortality.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Anna Farrús Torrellalead
- Hospital Clinic of Barcelonacollaborator
Study Sites (1)
Hospital Clínic de Barcelona
Barcelona, Barcelona, 08036, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Farrús Torrella, RN, MSc, PhD Candidate
Hospital Clínic de Barcelona/Universitat de Barcelona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 17, 2026
First Posted
July 2, 2026
Study Start
January 20, 2024
Primary Completion
February 2, 2026
Study Completion
February 2, 2026
Last Updated
July 8, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share